Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Rising Rates of COVID-19 Infection in Parts of Latin America, While Haiti Has Not Yet Started Vaccinations 08/07/2021 Raisa Santos Though the Americas is the only World Health Organization (WHO) region that is reporting a slight decline in new COVID-19 cases this week, countries in Central and South America, Canada and Mexico are still experiencing rising rates of infection. Over 1.1 million new COVID-19 cases were reported in the Americas over the last week, officials […] Continue reading -> Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Rising Rates of COVID-19 Infection in Parts of Latin America, While Haiti Has Not Yet Started Vaccinations 08/07/2021 Raisa Santos Though the Americas is the only World Health Organization (WHO) region that is reporting a slight decline in new COVID-19 cases this week, countries in Central and South America, Canada and Mexico are still experiencing rising rates of infection. Over 1.1 million new COVID-19 cases were reported in the Americas over the last week, officials […] Continue reading -> Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Rising Rates of COVID-19 Infection in Parts of Latin America, While Haiti Has Not Yet Started Vaccinations 08/07/2021 Raisa Santos Though the Americas is the only World Health Organization (WHO) region that is reporting a slight decline in new COVID-19 cases this week, countries in Central and South America, Canada and Mexico are still experiencing rising rates of infection. Over 1.1 million new COVID-19 cases were reported in the Americas over the last week, officials […] Continue reading -> Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Rising Rates of COVID-19 Infection in Parts of Latin America, While Haiti Has Not Yet Started Vaccinations 08/07/2021 Raisa Santos Though the Americas is the only World Health Organization (WHO) region that is reporting a slight decline in new COVID-19 cases this week, countries in Central and South America, Canada and Mexico are still experiencing rising rates of infection. Over 1.1 million new COVID-19 cases were reported in the Americas over the last week, officials […] Continue reading -> Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Rising Rates of COVID-19 Infection in Parts of Latin America, While Haiti Has Not Yet Started Vaccinations 08/07/2021 Raisa Santos Though the Americas is the only World Health Organization (WHO) region that is reporting a slight decline in new COVID-19 cases this week, countries in Central and South America, Canada and Mexico are still experiencing rising rates of infection. Over 1.1 million new COVID-19 cases were reported in the Americas over the last week, officials […] Continue reading -> Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Rising Rates of COVID-19 Infection in Parts of Latin America, While Haiti Has Not Yet Started Vaccinations 08/07/2021 Raisa Santos Though the Americas is the only World Health Organization (WHO) region that is reporting a slight decline in new COVID-19 cases this week, countries in Central and South America, Canada and Mexico are still experiencing rising rates of infection. Over 1.1 million new COVID-19 cases were reported in the Americas over the last week, officials […] Continue reading -> Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Rising Rates of COVID-19 Infection in Parts of Latin America, While Haiti Has Not Yet Started Vaccinations 08/07/2021 Raisa Santos Though the Americas is the only World Health Organization (WHO) region that is reporting a slight decline in new COVID-19 cases this week, countries in Central and South America, Canada and Mexico are still experiencing rising rates of infection. Over 1.1 million new COVID-19 cases were reported in the Americas over the last week, officials […] Continue reading -> Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Countries Urged to Reopen with Caution as World Surpasses Four Million COVID Deaths 07/07/2021 Madeleine Hoecklin WHO urged high income countries in Europe and elsewhere to reconsider the reopening of mass events, and keep strict social distancing rules in place – in the wake of a surge in COVID cases almost everywhere but Latin America. They spoke at a press briefing on the day that the world passed the tragic milestone […] Continue reading -> New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Study Suggests COVID-19 Vaccines Could be Approved Based on Antibody Levels Induced – Before Phase 3 Trials Are Finished 07/07/2021 Madeleine Hoecklin Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca. Knowledge […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Posts navigation Older postsNewer posts